Celmatix Therapeutics

Biotechnology ResearchNew York, United States11-50 Employees

Celmatix Therapeutics is a preclinical-stage biotechnology company focused on women's health, based at 14 Wall Street in New York, NY 10005. It operates within biotechnology research and has a team of 11 to 50 employees. The company is developing a growing pipeline that includes an AMHR2 agonist program targeting ovarian aging, an oral FSH therapy for infertility, and a JNK inhibitor program for endometriosis. Recent milestones include launching a novel endometriosis drug program and participation in ARPA-H's Sprint for Women's Health initiative to support women's health research. More information is available on its website at celmatix.com.

Sign up for free to view info

Email Format Employee directory